MBMustafa Kemal Bayar

Mustafa Kemal Bayar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mustafa Kemal Bayar has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of subclavian vein and inferior vena cava collapsibility index in the intensive care unit

    by Serkan Solak, Suheyla Karadag Erkoç, Onat Ahmet Bermede, Mustafa Kemal Bayar

    The aim of this study was to evaluate the correlation between changes in the inferior vena cava collapsibility index and subclavian vein collapsibility index in patients undergoing passive leg raising tests in the intensive care unit, considering that respiratory changes affecting the inferior vena cava may similarly affect the subclavian vein.

  • Open Access

    Dark Side of the COVID-19 Pandemic; ‘Long COVID’

    by Elif Mukime Saricaoglu, Gule Cinar, Alpay Azap, Mustafa K. Bayar, Canan Tokay-Isıkay, Sehim Kutlayacaksın, Sinan Ibis

    Objective: Besides its morbidity and mortality all over the world, SARS-CoV-2 infection maintains its importance with prolonged symptoms after acute disease. The post-infectious period including a heterogeneous group of symptoms is named ‘long COVID’. This study aimed to describe persisting symptoms three months after COVID-19 and risk factors associated with ‘long COVID’. Materials and Methods: This cross-sectional retrospective study included COVID-19 patients diagnosed with SARS-CoV-2 PCR positivity in the first 18 months of the COVID-19 pandemic, between March 2020 and September 2021. We conducted a survey in 2022 to inquire about the participants’ symptoms that lasted three months or more after their own COVID-19 period. All patients were employees of one of the biggest national banks in Turkey. Participants answered a total of 31 questions over the phone. The presence of one or more symptoms persisting ≥3 months was defined as ‘long COVID’. The risk factors associated with ‘long COVID’ were determined. Results: A total of 1301 patients were included in our study. The median age of patients was 40 (22-57), and 558 (42.9%) were women. 257 (19.8%) patients had ‘long COVID’ symptoms. The most prevalent symptoms were myalgia (14.3%), arthralgia (14.1%), and back pain (13.8%). Female gender (p=0.000, OR=2.19 [95% CI=1.655-2.904]) and diabetes mellitus (p=0.016, OR=2.43 [95% CI=1.177-5.017]) were found as independent risk factors for ‘long COVID’ by multivariant logistic regression analysis. Conclusion: Female gender and diabetes mellitus are risk factors for ‘long COVID’. Detecting patients with a high risk for developing ‘long COVID’ is crucial for their management during the COVID and post-COVID periods. Keywords: COVID-19, long COVID, post COVID


  • Potentially Inappropriate Treatments in Intensive Care Units (INAPPT-ICU): Point Prevalence Study

    by Elif Erdoğan Öngel, Hülya Sungurtekin, Dilek Memiş, Demet Tok Aydın, Hilal Ayoğlu, Ferruh Ayoğlu, Işıl Özkoçak Turan, Çetin Kaymak, Dilek Özcengiz, Mustafa Kemal Bayar, et al.

    Amaç: Teknolojik gelişmeler, son dönem hastalıkları olan terminal hastaların yaşam sürelerinin uzamasına neden olmuştur. Yoğun bakım ünitelerinde (YBÜ) yaşam sonu bakım, terminal hastaların YBÜ’ye kabullerindeki yükselme ile artmıştır. Bu çalışmadaki amacımız, terminal hastaların YBÜ’deki prevalansını ve YBÜ’de potansiyel olarak yersiz tedavilerin nedenlerini incelemektir. Gereç ve Yöntem: Çalışmamız ülke çapında, çok merkezli, nokta prevalans ve gözlemsel olarak yapıldı. YBÜ’de 48 saatten fazla kalan tüm yetişkin hastalar çalışmaya alındı. Tüm hastalar, hasta demografisi, tedaviler, aile katılımı ve hekimler için mini anket ile ilgili verilerden oluşan elektronik bir olgu kayıt formuna kaydedildi. Çalışma, 15 Ekim 2018’de 30 günlük bir takip ile gerçekleştirildi. Bulgular: Kaydedilen tüm 1127 hastanın 286’sına (%25) primer hekimi beyanına göre YBÜ hekimleri tarafından terminal hasta tanısı konuldu. Terminal hasta yakınlarının talepleri ve hekimlerin yasal kaygılarının yaşam sonu bakım kalitesini düşürdüğü görüldü. Terminal hastalarda mekanik ventilasyon kullanımı, inotropik ilaçlar ve düşük yaşam sonu bakım kalitesi önemli ölçüde fazlaydı (p


  • Living Donor Liver Transplantation Early Period Outcomes with the High MELD-Na Scores: Single Center Experience

    by Süheyla Karadağ Erkoç, Elif Beyza Başkan, Yonca Altunbaş, Elvan Onur Kırımker, Deniz Balcı, Mustafa Kemal Bayar, Ali Abbas Yılmaz


  • Trauma-related Admissions to Intensive Care Unit: Single Center Experience for Major Trauma

    by Süheyla Karadağ Erkoç, Pınar Karabak, Volkan Baytaş, Ali Abbas Yılmaz, Mustafa Kemal Bayar


  • Validating A New Software for 3D reconstruction and Volumetric Analysis in Living Donor Liver Transplantation

    by Deniz Balci, Onur Elvan Kirimker, Meltem Kologlu, Evren Ustuner, Suheyla Karadag Erkoc, Ali Abbas Yilmaz, Mustafa Kemal Bayar, Hasan Ozkan, Necati Ormeci, Kaan Karayalcin


  • Open Access

    Masif Pulmoner Tromboembolide Hangi Hastaya Hangi Doz Trombolitik Verilmeli? İki Olgu Sunumu

    by Behiye Deniz Kosovalı, Asiye Yavuz, Fatma İrem Yeşiler, Ahmet Eskiocak, Mustafa Kemal Bayar

    Masif pulmoner tromboemboli (PTE) ani başlangıçlı dispne, hipotansiyon, sağ kalp yetmezliği bulguları, presenkop veya senkop ve kardiyak arrest ile karşımıza çıkabilen, hemen tanı konulup tedavisinin başlanması gereken bir durumdur. Masif PTE mortalitesi ve morbiditesi yüksek, acil ve ciddi bir klinik tablodur. Tedavi sırasında yakın izlem ve monitorizasyonun yanı sıra ciddi hipoksemi nedeniyle çoğu kez mekanik ventilasyon gereksinimi olduğundan yoğun bakım ünitelerinde takibi uygundur. Masif PTE algoritmasına göre hemodinamik olarak stabil olmayan hastalarda tanı amacıyla yatak başı ekokardiyografide sağ ventrikül disfonksiyonunu gösterir ve trombolitik tedavi kontrendike değilse hemen verilir. Verilen trombolitik dozunun hasta ve hastalığın özelliğine göre seçilmesi uygun bir yaklaşımdır. Nefes darlığı, göğüs ağrısı ve senkop nedeniyle acil servise başvuran iki masif PTE olgusu farklı dozlarda trombolitik tedavi ile başarılı bir şekilde tedavi edildi ve olgular literatür bilgileri ışığında değerlendirildi.

  • Open Access

    Melkersson-Rosenthal Syndrome: A Rare Cause of Recurrent Facial Nerve Palsy and Acute Respiratory Distress Syndrome

    by Behiye Deniz Kosovali, Asiye Yavuz, Fatma Irem Yesiler, Mustafa Kemal Bayar

    Melkersson-Rosenthal Syndrome (MRS) is a rare disease characterized by persistent or recurrent orofacial oedema, relapsing peripheral facial paralysis, and furrowed tongue. Pathologically, granulomatosis is responsible for oedema of face, labia, oral cavity, and facial nerve. We present a patient with MRS admitted to our hospital with acute respiratory distress syndrome (ARDS). 45-year-old woman was admitted to an emergency department with dyspnea and swelling on her hands and face. She was intubated because of ARDS and accepted to intensive care unit (ICU). After weaning from ventilatory support, peripheral facial paralysis was diagnosed and steroid treatment was added to her therapy. On dermatologic examination, oedema on her face, pustular lesions on her skin, and fissure on her tongue were detected. The patient informed us about her recurrent and spontaneous facial paralysis in previous years. According to her history and clinical findings, MRS was diagnosed.


  • Open Access

    Outcomes of Antepartum and Postpartum Obstetric Admissions to the Intensive Care Unit of A Tertiary University Hospital: An 8-Year Review

    by Menekse Ozcelik, Sanem Turhan, Onat Bermede, Ali Abbas Yilmaz, Necmettin Unal, Mustafa Kemal Bayar

    Although their rates are decreasing, pregnancy-related mortality and morbidity are problems worldwide. In this study, we aimed to review the characteristics, diagnoses, required interventions and outcomes of obstetric patients admitted between 2006 and 2014 to the Intensive Care Unit (ICU) of a tertiary university hospital to provide an indicator for improving the management of critically ill obstetric patients. A retrospective study of hospital records of obstetric admissions to the ICU was conducted. The pregnancy-related ICU admission rate was 0.21% among all deliveries during the study period. Nine antepartum (mean gestational age: 23 weeks) and 48 postpartum (mean gestational age: 34 weeks) obstetric ICU admissions were included. Most obstetric patients admitted antepartum were primiparous (88.8%), whereas those admitted postpartum were multiparous (64.6%). The mean ICU stay was 7 days among the patients admitted antepartum and 6 days among those admitted postpartum. Common medical reasons for ICU admission were respiratory failure and HELLP syndrome in both groups; DIC and eclampsia were also medical reasons causing ICU admission among the postpartum patients. Mechanical ventilation and blood derivative transfusion were the most common interventions required during the ICU stay of the obstetric patients. Maternal death was unique to the patients admitted postpartum (6 patients, 12.5%). We reviewed obstetric admissions to our institution over an 8-year period. We believe that a nationwide study in Turkey that provides an indicator of the frequency, reasons of ICU admission and outcome of obstetric patients is required to improve the quality of intensive care.


  • Open Access

    Anesthesia and Intensive Care Management in a Pregnant Woman with PRES: A Case Report

    by Ismail Demirel, Ayse Belin Ozer, Mustafa K. Bayar, Salih Burcin Kavak

    Posterior reversible encephalopathy syndrome (PRES) is a temporary condition that is diagnosed clinically, neurologically, and radiologically. Its symptoms vary, and nonspecific headaches, confusion, impairment of consciousness, nausea, vomiting, and visual impairment may occur. Acute hypertension often accompanies these symptoms. Patients can also suffer from convulsions, cortical visual impairment, and coma. Diagnosis can be difficult due to focal neurologic signs. Nevertheless, knowing the clinical risk factors can lead to the right diagnosis. It has been reported that this condition may also occur during organ transplantation, immunosuppressive treatment, and autoimmune diseases and chemotherapy, and also patients with eclampsia. In this paper, a 21-year-old, 31-week pregnant woman, who had been diagnosed with PRES and thanks to early diagnosis and treatment had fully recovered and discharged from the intensive care unit, is presented, and the relevant literature is discussed.